ID   ENPP7_HUMAN             Reviewed;         458 AA.
AC   Q6UWV6; Q6ZTS5; Q8IUS8;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 3.
DT   10-MAY-2017, entry version 123.
DE   RecName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 7;
DE            Short=E-NPP 7;
DE            Short=NPP-7;
DE            EC=3.1.4.12;
DE   AltName: Full=Alkaline sphingomyelin phosphodiesterase;
DE   AltName: Full=Intestinal alkaline sphingomyelinase;
DE            Short=Alk-SMase;
DE   Flags: Precursor;
GN   Name=ENPP7 {ECO:0000312|EMBL:AAH41453.2}; ORFNames=UNQ3077/PRO9912;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAP69661.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 137-151; 239-248;
RP   256-271 AND 313-326, VARIANT PRO-4, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Colon {ECO:0000269|PubMed:12885774},
RC   Kidney {ECO:0000269|PubMed:12885774},
RC   Small intestine {ECO:0000269|PubMed:12885774}, and
RC   Stomach {ECO:0000269|PubMed:12885774};
RX   PubMed=12885774; DOI=10.1074/jbc.M305437200;
RA   Duan R.-D., Bergman T., Xu N., Wu J., Cheng Y., Duan J., Nelander S.,
RA   Palmberg C., Nilsson A.;
RT   "Identification of human intestinal alkaline sphingomyelinase as a
RT   novel ecto-enzyme related to the nucleotide phosphodiesterase
RT   family.";
RL   J. Biol. Chem. 278:38528-38536(2003).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAQ88985.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAC86504.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-4.
RC   TISSUE=Liver {ECO:0000312|EMBL:BAC86504.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAH41453.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-4.
RC   TISSUE=Colon {ECO:0000312|EMBL:AAH41453.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [6] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12671034; DOI=10.1194/jlr.M300037-JLR200;
RA   Duan R.-D., Cheng Y., Hansen G., Hertervig E., Liu J.-J., Syk I.,
RA   Sjostrom H., Nilsson A.;
RT   "Purification, localization, and expression of human intestinal
RT   alkaline sphingomyelinase.";
RL   J. Lipid Res. 44:1241-1250(2003).
RN   [7] {ECO:0000305}
RP   MUTAGENESIS OF HIS-353.
RX   PubMed=15016655; DOI=10.1093/carcin/bgh140;
RA   Wu J., Cheng Y., Nilsson A., Duan R.-D.;
RT   "Identification of one exon deletion of intestinal alkaline
RT   sphingomyelinase in colon cancer HT-29 cells and a differentiation-
RT   related expression of the wild-type enzyme in Caco-2 cells.";
RL   Carcinogenesis 25:1327-1333(2004).
RN   [8] {ECO:0000305}
RP   GLYCOSYLATION AT ASN-100; ASN-121; ASN-146; ASN-168 AND ASN-267, AND
RP   MUTAGENESIS OF SER-76; CYS-78; ASN-100; ASN-121; ASN-146; ASN-168 AND
RP   ASN-267.
RX   PubMed=15458386; DOI=10.1042/BJ20041455;
RA   Wu J., Hansen G.H., Nilsson A., Duan R.-D.;
RT   "Functional studies of human intestinal alkaline sphingomyelinase by
RT   deglycosylation and mutagenesis.";
RL   Biochem. J. 386:153-160(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-146.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: Converts sphingomyelin to ceramide. Also has
CC       phospholipase C activity toward palmitoyl lyso-phosphocholine.
CC       Does not appear to have nucleotide pyrophosphatase activity.
CC       {ECO:0000269|PubMed:12885774}.
CC   -!- CATALYTIC ACTIVITY: Sphingomyelin + H(2)O = N-acylsphingosine +
CC       phosphocholine. {ECO:0000269|PubMed:12885774}.
CC   -!- ENZYME REGULATION: Inhibited in a dose dependent manner by ATP,
CC       imidazole, orthovanadate and zinc ion. Not inhibited by ADP, AMP
CC       and EDTA. {ECO:0000269|PubMed:12885774}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:12671034,
CC       ECO:0000305}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:12671034, ECO:0000305}. Note=Localized at the
CC       surface of the microvillar membrane in small intestine
CC       enterocytes, and in endosome-like structures situated beneath the
CC       microvillar membrane, and in Golgi complex.
CC       {ECO:0000269|PubMed:12671034, ECO:0000269|PubMed:12885774}.
CC   -!- TISSUE SPECIFICITY: Detected in the colon (at protein level).
CC       Expressed in the duodenum, jejunum and liver and at low levels in
CC       the ileum. Expression was very low in the esophagus, stomach and
CC       colon. {ECO:0000269|PubMed:12671034, ECO:0000269|PubMed:12885774}.
CC   -!- PTM: N-glycosylated; required for activity and transport to the
CC       plasma membrane. {ECO:0000269|PubMed:15458386,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- MISCELLANEOUS: Decreased levels of alkaline sphingomyelin
CC       phosphodiesterase may be associated with colon cancer.
CC       {ECO:0000303|PubMed:12671034, ECO:0000303|PubMed:15016655}.
CC   -!- SIMILARITY: Belongs to the nucleotide
CC       pyrophosphatase/phosphodiesterase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ENPP7ID44055ch17q25.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY230663; AAP69661.1; -; mRNA.
DR   EMBL; AY358622; AAQ88985.1; -; mRNA.
DR   EMBL; AK126250; BAC86504.1; -; mRNA.
DR   EMBL; BC041453; AAH41453.2; -; mRNA.
DR   CCDS; CCDS11763.1; -.
DR   RefSeq; NP_848638.3; NM_178543.4.
DR   UniGene; Hs.114084; -.
DR   PDB; 5TCD; X-ray; 2.40 A; A=22-433.
DR   PDB; 5UDY; X-ray; 2.60 A; A=22-433.
DR   PDBsum; 5TCD; -.
DR   PDBsum; 5UDY; -.
DR   ProteinModelPortal; Q6UWV6; -.
DR   SMR; Q6UWV6; -.
DR   BioGrid; 130844; 9.
DR   IntAct; Q6UWV6; 8.
DR   STRING; 9606.ENSP00000332656; -.
DR   ChEMBL; CHEMBL6058; -.
DR   SwissLipids; SLP:000000173; -.
DR   PhosphoSitePlus; Q6UWV6; -.
DR   DMDM; 134047772; -.
DR   PaxDb; Q6UWV6; -.
DR   PeptideAtlas; Q6UWV6; -.
DR   PRIDE; Q6UWV6; -.
DR   Ensembl; ENST00000328313; ENSP00000332656; ENSG00000182156.
DR   GeneID; 339221; -.
DR   KEGG; hsa:339221; -.
DR   UCSC; uc002jxa.5; human.
DR   CTD; 339221; -.
DR   DisGeNET; 339221; -.
DR   GeneCards; ENPP7; -.
DR   H-InvDB; HIX0027161; -.
DR   HGNC; HGNC:23764; ENPP7.
DR   HPA; HPA024603; -.
DR   MIM; 616997; gene.
DR   neXtProt; NX_Q6UWV6; -.
DR   PharmGKB; PA134986550; -.
DR   eggNOG; KOG2645; Eukaryota.
DR   eggNOG; COG1524; LUCA.
DR   HOGENOM; HOG000231018; -.
DR   HOVERGEN; HBG106748; -.
DR   InParanoid; Q6UWV6; -.
DR   KO; K12354; -.
DR   OrthoDB; EOG091G06NA; -.
DR   PhylomeDB; Q6UWV6; -.
DR   TreeFam; TF330032; -.
DR   BRENDA; 3.1.4.12; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   GeneWiki; ENPP7; -.
DR   GenomeRNAi; 339221; -.
DR   PRO; PR:Q6UWV6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000182156; -.
DR   CleanEx; HS_ENPP7; -.
DR   ExpressionAtlas; Q6UWV6; baseline and differential.
DR   Genevisible; Q6UWV6; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0008156; P:negative regulation of DNA replication; IDA:UniProtKB.
DR   GO; GO:0006685; P:sphingomyelin catabolic process; IEA:InterPro.
DR   GO; GO:0006684; P:sphingomyelin metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR029895; ENPP7.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   PANTHER; PTHR10151:SF87; PTHR10151:SF87; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Glycoprotein; Hydrolase; Membrane; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255,
FT                                ECO:0000269|PubMed:15340161}.
FT   CHAIN        22    458       Ectonucleotide
FT                                pyrophosphatase/phosphodiesterase family
FT                                member 7.
FT                                /FTId=PRO_0000036403.
FT   TRANSMEM    434    454       Helical. {ECO:0000255}.
FT   REGION       72     78       Required for enzyme activity.
FT   ACT_SITE     75     75       Nucleophile. {ECO:0000250}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15458386}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15458386}.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15458386,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15458386}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15458386}.
FT   VARIANT       4      4       L -> P (in dbSNP:rs8074547).
FT                                {ECO:0000269|PubMed:12885774,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_021506.
FT   MUTAGEN      76     76       S->F: Loss of activity.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN      78     78       C->N: Strongly reduces activity.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     100    100       N->Q: Strongly reduces N-glycosylation
FT                                and enzyme activity; when associated with
FT                                Q-121; Q-146; Q-168 and Q-267.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     121    121       N->Q: Strongly reduces N-glycosylation
FT                                and enzyme activity; when associated with
FT                                Q-100; Q-146; Q-168 and Q-267.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     146    146       N->Q: Strongly reduces N-glycosylation
FT                                and enzyme activity; when associated with
FT                                Q-100; Q-146; Q-168 and Q-267.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     168    168       N->Q: Strongly reduces N-glycosylation
FT                                and enzyme activity; when associated with
FT                                Q-100; Q-121; Q-168 and Q-267.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     267    267       N->Q: Strongly reduces N-glycosylation
FT                                and enzyme activity; when associated with
FT                                Q-100; Q-121; Q-146 and Q-168.
FT                                {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:15458386}.
FT   MUTAGEN     353    353       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:15016655}.
FT   CONFLICT    101    101       T -> I (in Ref. 2; AAQ88985).
FT                                {ECO:0000305}.
FT   CONFLICT    388    388       Y -> N (in Ref. 3; BAC86504).
FT                                {ECO:0000305}.
SQ   SEQUENCE   458 AA;  51494 MW;  F6A06913C33E4398 CRC64;
     MRGLAVLLTV ALATLLAPGA GAPVQSQGSQ NKLLLVSFDG FRWNYDQDVD TPNLDAMARD
     GVKARYMTPA FVTMTSPCHF TLVTGKYIEN HGVVHNMYYN TTSKVKLPYH ATLGIQRWWD
     NGSVPIWITA QRQGLRAGSF FYPGGNVTYQ GVAVTRSRKE GIAHNYKNET EWRANIDTVM
     AWFTEEDLDL VTLYFGEPDS TGHRYGPESP ERREMVRQVD RTVGYLRESI ARNHLTDRLN
     LIITSDHGMT TVDKRAGDLV EFHKFPNFTF RDIEFELLDY GPNGMLLPKE GRLEKVYDAL
     KDAHPKLHVY KKEAFPEAFH YANNPRVTPL LMYSDLGYVI HGRINVQFNN GEHGFDNKDM
     DMKTIFRAVG PSFRAGLEVE PFESVHVYEL MCRLLGIVPE ANDGHLATLL PMLHTESALP
     PDGRPTLLPK GRSALPPSSR PLLVMGLLGT VILLSEVA
//
